# Innate Immunity

## Overview

Innate immunity is the first line of defense against pathogens, providing immediate but non-specific protection. Unlike adaptive immunity, it does not require prior exposure to pathogens and responds within minutes to hours. It consists of physical barriers, cellular defenses, and molecular components that recognize and eliminate threats.

### Key Characteristics
- **Immediate response**: No memory required, acts within minutes
- **Non-specific**: Recognizes broad categories of pathogens
- **Evolutionary conserved**: Similar mechanisms across species
- **Pattern recognition**: Detects pathogen-associated molecular patterns (PAMPs)

## Physical and Chemical Barriers

### Skin
- **Epidermis**: Keratinized stratified squamous epithelium
- **Acidic pH**: 5.5, inhibits bacterial growth
- **Sebaceous secretions**: Antimicrobial fatty acids
- **Normal flora**: Competitive exclusion of pathogens

### Mucous Membranes
- **Mucus**: Traps pathogens and particles
- **Ciliary action**: Mucociliary escalator removes debris
- **Antimicrobial peptides**: Defensins, lysozyme, lactoferrin
- **Secretory IgA**: Prevents pathogen attachment

### Specialized Barriers
- **Gastric acid**: pH 1-3, kills most bacteria
- **Bile salts**: Antimicrobial action in intestine
- **Urine flow**: Mechanical flushing of urinary tract
- **Tears**: Lysozyme and antimicrobial peptides

## Cellular Components

### Neutrophils
- **Most abundant**: 50-70% of circulating leukocytes
- **First responders**: Recruited within minutes to hours
- **Functions**: Phagocytosis, degranulation, NETosis
- **Lifespan**: 6-8 hours in circulation, 1-2 days in tissues

### Macrophages
- **Tissue residents**: Present in all organs
- **Functions**: Phagocytosis, antigen presentation, tissue repair
- **Polarization**: M1 (pro-inflammatory) vs M2 (anti-inflammatory)
- **Origin**: Monocytes differentiate into tissue macrophages

### Natural Killer (NK) Cells
- **Target**: Virus-infected and tumor cells
- **Recognition**: Missing self (decreased MHC I expression)
- **Cytotoxicity**: Perforin, granzymes, death receptor ligands
- **Cytokine production**: IFN-γ, TNF-α

### Dendritic Cells
- **Antigen presentation**: Bridge innate and adaptive immunity
- **Pattern recognition**: Express multiple PRRs
- **Maturation**: Pathogen exposure triggers activation
- **Migration**: From tissues to lymph nodes

### Eosinophils
- **Parasitic infections**: Primary defense against helminths
- **Allergic reactions**: Contribute to tissue damage
- **Granule proteins**: Major basic protein, eosinophil peroxidase
- **Lifespan**: 8-12 hours in circulation

### Basophils and Mast Cells
- **Allergic reactions**: IgE-mediated degranulation
- **Mediators**: Histamine, leukotrienes, prostaglandins
- **Tissue distribution**: Mast cells in tissues, basophils circulating
- **Functions**: Vasodilation, smooth muscle contraction

## Pattern Recognition Receptors (PRRs)

### Toll-like Receptors (TLRs)
- **Location**: Cell surface and endosomes
- **Recognition**: Specific PAMPs (LPS, flagellin, dsRNA)
- **Signaling**: MyD88-dependent and independent pathways
- **Outcome**: Cytokine production, type I interferon response

### NOD-like Receptors (NLRs)
- **Location**: Cytoplasm
- **Function**: Detect intracellular PAMPs and DAMPs
- **Inflammasome**: NLRP3, ASC, caspase-1 complex
- **IL-1β production**: Key inflammatory cytokine

### RIG-I-like Receptors (RLRs)
- **Viral RNA detection**: Cytoplasmic viral nucleic acids
- **Type I interferons**: Antiviral protein production
- **Signaling**: MAVS-dependent pathway

### C-type Lectin Receptors
- **Carbohydrate recognition**: Pathogen surface sugars
- **Examples**: Dectin-1 (β-glucan), mannose receptor
- **Functions**: Phagocytosis, cytokine production

## Complement System

### Complement Pathways
1. **Classical pathway**: Antibody-antigen complexes (C1q)
2. **Alternative pathway**: Pathogen surfaces directly
3. **Lectin pathway**: Mannose-binding lectin (MBL)

### Complement Functions
- **Lysis**: Membrane attack complex (MAC) formation
- **Opsonization**: C3b coating enhances phagocytosis
- **Inflammation**: C3a, C5a anaphylatoxins
- **Immune clearance**: Removal of immune complexes

### Regulation
- **Fluid phase**: Factor H, Factor I, C4-binding protein
- **Membrane bound**: CD55 (DAF), CD46 (MCP), CD55 (CR1)
- **Terminal pathway**: CD59 inhibits MAC formation

## Inflammatory Response

### Acute Inflammation
- **Vasodilation**: Increased blood flow to affected area
- **Increased permeability**: Plasma protein extravasation
- **Cellular recruitment**: Neutrophil migration to tissues
- **Cardinal signs**: Rubor, calor, dolor, tumor, functio laesa

### Inflammatory Mediators
- **Histamine**: Immediate vasodilation and permeability
- **Prostaglandins**: Pain, fever, vasodilation
- **Leukotrienes**: Smooth muscle contraction, permeability
- **Cytokines**: IL-1β, TNF-α, IL-6 (systemic effects)

### Resolution of Inflammation
- **Lipoxins**: Pro-resolving mediators
- **Resolvins**: Omega-3 fatty acid derivatives
- **Protectins**: Neuroprotective anti-inflammatory mediators
- **Efferocytosis**: Macrophage clearance of apoptotic cells

## Antimicrobial Mechanisms

### Phagocytosis
1. **Recognition**: PRR binding to PAMPs
2. **Engulfment**: Phagosome formation
3. **Phagolysosome fusion**: Delivery of antimicrobial contents
4. **Killing**: Oxidative and non-oxidative mechanisms

### Antimicrobial Peptides
- **Defensins**: α-defensins (neutrophils), β-defensins (epithelia)
- **Cathelicidin (LL-37)**: Broad-spectrum antimicrobial
- **Lysozyme**: Peptidoglycan degradation
- **Lactoferrin**: Iron sequestration

### Reactive Oxygen Species
- **NADPH oxidase**: Superoxide generation
- **Myeloperoxidase**: Hypochlorous acid production
- **Nitric oxide synthase**: NO production
- **Oxidative burst**: Rapid ROS generation

## Interferon Response

### Type I Interferons (IFN-α/β)
- **Viral detection**: RLR and TLR signaling
- **Antiviral state**: ISG induction in neighboring cells
- **Functions**: Protein synthesis inhibition, viral replication block
- **Immune activation**: NK cell and T cell stimulation

### Type II Interferon (IFN-γ)
- **Source**: NK cells, Th1 cells
- **Macrophage activation**: Enhanced antimicrobial activity
- **MHC upregulation**: Improved antigen presentation
- **Th1 polarization**: Cell-mediated immunity

### Type III Interferons (IFN-λ)
- **Epithelial protection**: Mucosal surface antiviral defense
- **Limited receptor distribution**: IL-28R expression
- **Antiviral activity**: Similar to type I IFNs

## Clinical Applications

### Immunodeficiencies
- **Chronic granulomatous disease**: NADPH oxidase deficiency
- **Leukocyte adhesion deficiency**: Integrin defects
- **Complement deficiencies**: Increased infection susceptibility
- **NK cell deficiencies**: Viral and tumor susceptibility

### Autoinflammatory Diseases
- **Familial Mediterranean fever**: NLRP3 inflammasome mutations
- **Cryopyrin-associated syndromes**: NLRP3 gain-of-function
- **Systemic juvenile arthritis**: IL-1β overproduction

### Therapeutic Targets
- **TLR agonists**: Vaccine adjuvants
- **Complement inhibitors**: C5 inhibition (eculizumab)
- **Anti-inflammatory drugs**: NSAIDs, corticosteroids
- **Cytokine blockade**: Anti-TNF-α, anti-IL-1β therapy

### Diagnostic Applications
- **Inflammatory markers**: CRP, ESR, procalcitonin
- **Complement levels**: C3, C4, CH50
- **Cytokine measurements**: Research and clinical monitoring
- **Flow cytometry**: Immune cell phenotyping

## Clinical Correlations

### Sepsis and SIRS
- **Pathogen recognition**: Massive PRR activation
- **Cytokine storm**: Excessive inflammatory response
- **Organ dysfunction**: Inflammation-mediated tissue damage
- **Treatment**: Supportive care, source control

### Allergic Reactions
- **Type I hypersensitivity**: IgE-mediated mast cell degranulation
- **Anaphylaxis**: Systemic mast cell activation
- **Treatment**: Epinephrine, antihistamines, corticosteroids

### Wound Healing
- **Hemostasis**: Platelet activation and coagulation
- **Inflammation**: Neutrophil and macrophage recruitment
- **Proliferation**: Tissue repair and angiogenesis
- **Remodeling**: Collagen reorganization

## Key Points

- Innate immunity provides immediate, non-specific defense against pathogens
- Physical and chemical barriers prevent pathogen entry
- Pattern recognition receptors detect conserved pathogen molecules
- Multiple cell types contribute to innate immune responses
- Complement system provides lysis, opsonization, and inflammatory signals
- Inflammatory response coordinates cellular and molecular defenses
- Interferon responses provide antiviral protection
- Dysregulation leads to immunodeficiency or autoinflammatory diseases
- Understanding innate immunity is crucial for vaccine development and immunotherapy
- Clinical applications include diagnostics, therapeutics, and disease monitoring

## References

1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 9th ed. Elsevier; 2017.
2. Murphy K, Weaver C. Janeway's Immunobiology. 9th ed. Garland Science; 2016.
3. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S3-23.